Cardiol Therapeutics Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Mar 31, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Commitments and Contingency
Commitments and Contingency
(i)The Corporation has leased premises from third parties. The minimum committed lease payments as at December 31, 2025, which include the lease liability payments, are as follows:
| | | | |
|---|---|---|---|
| Fiscal year | | | |
| 2026 | $107,222 | ||
| 2027 | | 107,222 | |
| 2028 | | 89,351 | |
| Total | | $303,795 | |
(ii)The Corporation has signed various agreements with consultants to provide services. Under the agreements, the Corporation has the following remaining commitments.
| | | | |
|---|---|---|---|
| Fiscal year | | | |
| 2026 | | $306,915 | |
| 2027 | | | 34,435 |
| Total | | $341,350 |
(iii)Pursuant to the terms of agreements with various other contract research organizations, the Corporation is committed for the following contract research services:
| · · · | ||
|---|---|---|
| Fiscal year · · · | ||
| 2026 | | $2,006,708 |
| 2027 | | 501,105 |
| 2028 | | 45,833 |
| 2029 | | 22,196 |
| Total | | $2,575,842 |
- 19 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.